Fulltext
The Full text is available in PDF.
International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
e-ISSN 2538-497X
p-ISSN 2538-4422
Translation Elongation Rate Measurement of Epstein-Barr Virus Strain GD1
Authors
1Dept. of Biology, Faculty of Science, University of Zabol, Zabol, Iran
*Corresponding Author: Corresponding author: Gholamreza Motalleb, Dept. of Biology, Faculty of Science, University of Zabol, Zabol, Iran, Tel: +98-5422242503, E-mail: Email: reza.motaleb@uoz.ac.ir
Published online:Dec 30, 2013
Article type:Research Article
Received:May 12, 2013
Accepted:Aug 11, 2013
How to Cite:Motalleb G. Translation Elongation Rate Measurement of Epstein-Barr Virus Strain GD1. Int J Cancer Manag. 2013;6(4):e80478. doi:
Abstract
Background: Epstein-Barr Virus (EBV) has a great co relationship with human malignancies such as gastric carcinoma. Synonymous codon investigations in viruses could help designing vaccine, to generate immunity. Codon Adaptation Index (CAI) has measured translation elongation rate, among the highly expressed genes. The aim of this study was: usage of “CAI” to measure translation efficiency to know how fast EBV-GD1 could produce its proteins.
Methods:The complete genomic sequences of human herpes virus 4 strain GD1 have retrieved from http://www.ncbi.nlm.nih.gov/sites/gquery (GenBank accession no. AY961628) to extract all protein-coding genes. The sequences have analyzed with DAMBE software.
Results: The results have shown that CAI values for the EBV-GD1 genes were 0.76356 ± 0.02957. The highest and lowest CAI values were 0.82233 and 0.68321 respectively. The results have shown that highly expressed genes mostly had more codon usage bias than low expressed genes.
Conclusion: The results provide and introduce not only a system, but also the principles in order to understand the pathogenesis and evolution of EBV-GD1, to open a window, in order to make a better product or vaccine to challenge with the virus
Highlights
Copyright
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
28
Oct
2017
Epstein-Barr Virus and Breast Carcinoma in Iran
Maryam Kazemi Aghdam,
Seyed Alireza Nadji,
Maliheh Khoddami,
Hoda Baghizadeh Dezfuli,
Yassaman Khademi
Kazemi Aghdam M, Nadji SA, Khoddami M, Baghizadeh Dezfuli H, Khademi Y. Epstein-Barr Virus and Breast Carcinoma in Iran. Jundishapur J Microbiol. 2017;10(10):e12800. doi: https://doi.org/10.5812/jjm.12800
30
Oct
2021
Association of Epstein–Barr Virus and Cytomegalovirus Infections with Esophageal Carcinoma
Jamal Sarvari,
Ahmad Habibi,
Afagh Moattari,
Amir Taher Eftehkar Sadat,
Mahin Ahangar Oskouee
Sarvari J, Habibi A, Moattari A, Eftehkar Sadat AT, Ahangar Oskouee M. Association of Epstein–Barr Virus and Cytomegalovirus Infections with Esophageal Carcinoma. Int J Cancer Manag. 2021;14(10):e114566. doi: https://doi.org/10.5812/ijcm.114566
11
Jun
2016
Epstein-Barr Virus Infection and Risk of Breast Cancer: An Adaptive Meta-Analysis for Case-Control Studies
Jong-Myon Bae,
Eun Hee Kim
Bae J, Kim EH. Epstein-Barr Virus Infection and Risk of Breast Cancer: An Adaptive Meta-Analysis for Case-Control Studies. Arch Clin Infect Dis. 2016;11(3):e34806. doi: https://doi.org/10.5812/archcid.34806
31
Dec
2008
Prevalence of Anti‐EBV Antibodies in Adult Patients with Nasopharyngeal Carcinoma During 2003‐2007 In Isfahan, Iran
M Mokhtari,
M Hashemi Jazi,
Amir Hosein Ddavarpanah Jaz
Mokhtari M, Hashemi Jazi M, Ddavarpanah Jaz AH. Prevalence of Anti‐EBV Antibodies in Adult Patients with Nasopharyngeal Carcinoma During 2003‐2007 In Isfahan, Iran. Int J Cancer Manag. 2008;1(4):e80603. doi:
Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 6 hours ago
- OpenAlex: 0
Last Update: 10 hours ago
- OpenCitations: 0
Last Update: 5 days ago
Comments
Number of Comments:0